Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Asha Das, MD
Tocagen Inc.
Study Director - Timothy Cloughesy, MD, NO
University of California, Los Angeles
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucla
Los Angeles, California, United States
- University of California at San Diego
San Diego, California, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- Jfk Medical Center
Edison, New Jersey, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Ohio State University
Columbus, Ohio, United States
- Swedish Neuroscience Institute
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Feb 2012
- Primary completion
- 12 Apr 2016
- Completion
- 12 Apr 2016
- Last update posted
- 21 May 2018
- Registered enrollment
- 58
- Registry id
- NCT01470794
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.